|
|
||||||||||
|
J Am Coll Cardiol, 2003; 42:446-453, doi:10.1016/S0735-1097(03)00654-5 © 2003 by the American College of Cardiology Foundation |
* University of Queensland, Brisbane, Australia
Manuscript received September 5, 2002; revised manuscript received January 12, 2003, accepted January 16, 2003.
* Reprint requests and correspondence: Prof. Thomas H. Marwick, University of Queensland Department of Medicine, Princess Alexandra Hospital, Ipswich Road, Brisbane, Qld 4012, Australia.
tmarwick{at}medicine.pa.uq.edu.au
OBJECTIVES: We sought to use quantitative markers of the regional left ventricular (LV) response to stress to infer whether diabetic cardiomyopathy is associated with ischemia.
BACKGROUND: Diabetic cardiomyopathy has been identified in clinical and experimental studies, but its cause remains unclear.
METHODS: We studied 41 diabetic patients with normal resting LV function and a normal dobutamine echo and 41 control subjects with a low probability of coronary disease. Peak myocardial systolic velocity (Sm) and early diastolic velocity (Em) in each segment were averaged, and mean Sm and Em were compared between diabetic patients and controls and among different stages of dobutamine stress.
RESULTS: Both Sm and Em progressively increased from rest to peak dobutamine stress. In the diabetic group, Sm was significantly lower than in control subjects at baseline (4.2 ± 0.9 cm/s vs. 4.7 ± 0.9 cm/s, p = 0.012). However, Sm at a low dose (6.0 ± 1.3), before peak (8.4 ± 1.8), and at peak stress (8.9 ± 1.8) in diabetic patients was not significantly different from that of controls (6.3 ± 1.4, 8.9 ± 1.6, and 9.6 ± 2.1 cm/s, respectively). The Em (cm/s) in the diabetic group (rest: 4.2 ± 1.2; low dose: 5.0 ± 1.4; pre-peak: 5.3 ± 1.1; peak: 5.9 ± 1.5) was significantly lower than that of controls (rest: 5.8 ± 1.5; low dose: 6.6 ± 1.5; pre-peak: 6.9 ± 1.3; peak: 7.3 ± 1.7; all p < 0.001). However, the absolute and relative increases in Sm or Em from rest to peak stress were similar in diabetic and control groups.
CONCLUSIONS: Subtle LV dysfunction is present in diabetic patients without overt cardiac disease. The normal response to stress suggests that ischemia due to small-vessel disease may not be important in early diabetic heart muscle disease.
| ||||||||||||||||||||||
This article has been cited by other articles:
![]() |
C. Weytjens, P. R. Franken, J. D'hooge, S. Droogmans, B. Cosyns, T. Lahoutte, and G. Van Camp Doppler myocardial imaging in the diagnosis of early systolic left ventricular dysfunction in diabetic rats Eur J Echocardiogr, May 1, 2008; 9(3): 326 - 333. [Abstract] [Full Text] [PDF] |
||||
![]() |
T H Marwick Diabetic heart disease Postgrad. Med. J., April 1, 2008; 84(990): 188 - 192. [Abstract] [Full Text] [PDF] |
||||
![]() |
J.-W. Ha, H.-C. Lee, E.-S. Kang, C.-M. Ahn, J.-M. Kim, J.-A. Ahn, S.-W. Lee, E.-Y. Choi, S.-J. Rim, J. K Oh, et al. Abnormal left ventricular longitudinal functional reserve in patients with diabetes mellitus: implication for detecting subclinical myocardial dysfunction using exercise tissue Doppler echocardiography Heart, December 1, 2007; 93(12): 1571 - 1576. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. d. l. Fuentes, A. L. Brown, S. J. Mathews, A. D. Waggoner, P. F. Soto, R. J. Gropler, and V. G. Davila-Roman Metabolic syndrome is associated with abnormal left ventricular diastolic function independent of left ventricular mass Eur. Heart J., March 1, 2007; 28(5): 553 - 559. [Abstract] [Full Text] [PDF] |
||||
![]() |
S Moir, L Hanekom, Z-Y Fang, B Haluska, C Wong, M Burgess, and T H Marwick Relationship between myocardial perfusion and dysfunction in diabetic cardiomyopathy: a study of quantitative contrast echocardiography and strain rate imaging Heart, October 1, 2006; 92(10): 1414 - 1419. [Abstract] [Full Text] [PDF] |
||||
![]() |
T H Marwick Diabetic heart disease Heart, March 1, 2006; 92(3): 296 - 300. [Abstract] [Full Text] [PDF] |
||||
![]() |
F A Flachskampf and J-U Voigt The interventricular septum is functionally bilayered: a fresh look at a well known structure Heart, October 1, 2005; 91(10): 1260 - 1261. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Kozakova, A. G. Fraser, S. Buralli, A. Magagna, A. Salvetti, E. Ferrannini, and C. Palombo Reduced Left Ventricular Functional Reserve in Hypertensive Patients With Preserved Function at Rest Hypertension, April 1, 2005; 45(4): 619 - 624. [Abstract] [Full Text] [PDF] |
||||
![]() |
Z. Y. Fang, J. B. Prins, and T. H. Marwick Diabetic Cardiomyopathy: Evidence, Mechanisms, and Therapeutic Implications Endocr. Rev., August 1, 2004; 25(4): 543 - 567. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Taegtmeyer and P. Razeghi Heart disease in diabetes--resist the beginnings J. Am. Coll. Cardiol., January 21, 2004; 43(2): 315 - 315. [Full Text] [PDF] |
||||
![]() |
E. Picano Reply J. Am. Coll. Cardiol., January 21, 2004; 43(2): 315 - 315. [Full Text] [PDF] |
||||
| HOME | SUBSCRIPTIONS | CURRENT ISSUE | PAST ISSUES | CARDIOSOURCE | SEARCH | HELP | FEEDBACK |